Key result
Major hypertension guidelines recommend personalizing older adult blood pressure targets based on frailty and functionality.
Why the study?
Clinical trial evidence for treating hypertension in very old patients with frailty, multimorbidity, and polypharmacy is limited, requiring a comparison of how recent major clinical guidelines approach management in this population.
A comparison of recent ESH, ESC, and AHA/ACC hypertension guidelines highlights the necessity for a personalized therapeutic approach in older adults that incorporates comprehensive evaluation of functionality and frailty to balance treatment benefits and potential harms.
Answers are grounded in this paper and cite their sources.
Supports frailty-based personalization in older adults; leaves open optimal targets for underrepresented frail, multimorbid populations.
Treatment of hypertension in older people is associated with significant health-related benefits. However, at very old age, in patients with frailty, multimorbidity, and polypharmacy, the benefits of treatment must be balanced against the potential for harm from adverse events. The evidence for treatment in such populations is limited because they typically have not been included in many clinical trials. In this article, we discuss the differences in the approach to management of hypertension in older patients between the three recent clinical guidelines: the European Society of Hypertension (2023–2024), European Society of Cardiology (2024) and the American Heart Association/American College of Cardiology (2025) guidelines. We conclude that the therapeutic approach to older persons should be personalized and should include a comprehensive evaluation of functionality and frailty. Balancing potential health-related benefits and harms should be the basis of all clinical decisions in this population, especially for individuals eluding simplistic classifications.
No takes yet. Share an insight, caveat, or question.
Gąsowski et al. (2026) conducted a review in Hypertension in older persons. Comparative review of 2023/2024 ESH, 2024 ESC, and 2025 AHA/ACC guidelines concludes hypertension management in older adults should be personalized based on functionality and frailty.
Synapse has enriched 10 related papers. Consider them for comparative context: